Taysha Gene Therapies Inc’s filing revealed that its Officer Rumana Haque-Ahmed acquired Company’s shares for reported $30479.0 on Sep 22 ’25. In the deal valued at $2.83 per share,10,770 shares were bought.
Then, Nagendran Sukumar sold 200,000 shares, generating $646,000 in total proceeds. Upon selling the shares at $3.23, the President and Head of R&D now owns 1,006,439 shares.
Before that, Nagendran Sukumar bought 200,000 shares. Taysha Gene Therapies Inc shares valued at $652,000 were divested by the Officer at a price of $3.26 per share.
BofA Securities initiated its Taysha Gene Therapies Inc [TSHA] rating to a Buy in a research note published on July 11, 2025; the price target was $8. A number of analysts have revised their coverage, including BMO Capital Markets’s analysts, who began to cover the stock in late June with a ‘”an Outperform”‘ rating. Piper Sandler began covering TSHA with “an Overweight” recommendation on April 09, 2024. Jefferies revised its rating on February 01, 2023. It rated TSHA as “a Hold” which previously was an “a Buy”.
Price Performance Review of TSHA
On Tuesday, Taysha Gene Therapies Inc [NASDAQ:TSHA] saw its stock jump 1.74% to $2.92. Over the last five days, the stock has gained 2.82%. Taysha Gene Therapies Inc shares have risen nearly 33.33% since the year began. Nevertheless, the stocks have risen 68.79% over the past one year. While a 52-week high of $3.40 was reached on 09/08/25, a 52-week low of $1.05 was recorded on 04/09/25.
Levels Of Support And Resistance For TSHA Stock
The 24-hour chart illustrates a support level at 2.88, which if violated will result in even more drops to 2.83. On the upside, there is a resistance level at 2.96. A further resistance level may holdings at 2.99.
How much short interest is there in Taysha Gene Therapies Inc?
A steep rise in short interest was recorded in Taysha Gene Therapies Inc stocks on 2025-08-29, growing by 2.57 million shares to a total of 40.78 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 38.21 million shares. There was a rise of 6.29%, which implies that there is a positive sentiment for the stock.
